Vanessa Rousseau

3.2k total citations
103 papers, 1.4k citations indexed

About

Vanessa Rousseau is a scholar working on Toxicology, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vanessa Rousseau has authored 103 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Toxicology, 17 papers in Neurology and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vanessa Rousseau's work include Pharmacovigilance and Adverse Drug Reactions (29 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Pharmaceutical studies and practices (11 papers). Vanessa Rousseau is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (29 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Pharmaceutical studies and practices (11 papers). Vanessa Rousseau collaborates with scholars based in France, Austria and Germany. Vanessa Rousseau's co-authors include Jean‐Louis Montastruc, François Montastruc, Haleh Bagheri, Geneviève Durrieu, Agnès Sommet, Leila Chebane, Emmanuelle Bondon‐Guitton, Jean‐Charles Soria, Delphine Abadie and Thierry Le Chevalier and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Vanessa Rousseau

95 papers receiving 1.4k citations

Peers

Countries citing papers authored by Vanessa Rousseau

Since Specialization

Citations

This map shows the geographic impact of Vanessa Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Rousseau more than expected).

Fields of papers citing papers by Vanessa Rousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Rousseau. The network helps show where Vanessa Rousseau may publish in the future.

Co-authorship network of co-authors of Vanessa Rousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Rousseau. A scholar is included among the top collaborators of Vanessa Rousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Rousseau. Vanessa Rousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Early Treatment of Spasticity After Stroke on Motor Recovery: Protocol for the Baclotox Multicenter, Double-Blind, Double-Dummy Randomized Controlled Trial 2025 ·JMIR Research Protocols ·(unknown), (unknown), (unknown), Claire Thalamas, Vanessa Rousseau, (unknown), X. De Boissezon, É. Castel-Lacanal, (unknown), (unknown)	0
2	North Atlantic Heat Transport Convergence Derived from a Regional Energy Budget Using Different Ocean Heat Content Estimates 2024 ·Surveys in Geophysics ·Benoît Meyssignac, (unknown), Michael Mayer, (unknown), Francisco M. Calafat, (unknown), Timothy P. Boyer, Lijing Cheng, Damien Desbruyères, Gaël Forget, Donata Giglio, Mikael Kuusela, Ricardo Locarnini, (unknown), (unknown), Alexey Mishonov, James Reagan, Vanessa Rousseau, Jérôme Benveniste	2
3	Subthalamic and nigral stimulation for freezing of gait in Parkinson's disease: Randomized pilot trial 2024 ·Journal of Parkinson s Disease ·Carlo Alberto Artusi, (unknown), Silvia Gallo, Domiziana Rinaldi, C. Campisi, Vanessa Rousseau, Claire Thalamas, Raquel Barbosa, Fabienne Ory‐Magne, Christine Brefel‐Courbon, Olivier Rascol, (unknown), (unknown), Maurizio Zibetti, Mario Giorgio Rizzone, Alberto Romagnolo, Gabriele Imbalzano, Leonardo Lopiano, Jean Luc Houeto, Margherita Fabbri	0
4	Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults 2024 ·SHILAP Revista de lepidopterología ·(unknown), Vanessa Rousseau, Geneviève Durrieu, (unknown), Antoine Yrondi, Agnès Sommet, Alexis Revet, François Montastruc	3
5	Validation des critères d’identification des patients opérés d’un décollement de rétine rhegmatogène au CHU de Toulouse 2023 ·Journal Français d Ophtalmologie ·(unknown), (unknown), Vanessa Rousseau, (unknown), (unknown), Pierre Fournié, (unknown), Vincent Soler	1
6	Trim33 masks a non-transcriptional function of E2f4 in replication fork progression 2023 ·Nature Communications ·Vanessa Rousseau, Elias Einig, (unknown), (unknown), Mathias Riebold, Tanja Poth, Mohamed Ali Jarboui, (unknown), Nikita Popov	4
7	Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort 2022 ·Joint Bone Spine ·Adeline Ruyssen‐Witrand, Vanessa Rousseau, Agnès Sommet, Philippe Goupille, Yannick Degboé, Arnaud Constantin	3
8	Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies 2022 ·Frontiers in Neurology ·Lionel Calvière, Celine S. Gathier, Marie Rafiq, (unknown), Vanessa Rousseau, Nicolas Raposo, Jean François Albucher, Alain Viguier, Thomas Geeraerts, Christophe Cognard, Gabriël J.E. Rinkel, Mervyn D. I. Vergouwen, Jean‐Marc Olivot	12
9	A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study 2021 ·Parkinsonism & Related Disorders ·Margherita Fabbri, (unknown), Guillaume Baille, Matthieu Béreau, Christine Brefel Courbon, Giovanni Castelnovo, Nicolas Carrière, Philippe Damier, Luc Defebvre, Anne Doé de Maindreville, Frédérique Fluchère, (unknown), David Grabli, David Maltête, Vanessa Rousseau, (unknown), Claire Thalamas, Claire Thiriez, Olivier Rascol, Fabienne Ory‐Magne	19
10	Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database 2020 ·Pediatric Drugs ·(unknown), Vanessa Rousseau, Florentia Kaguelidou, (unknown), (unknown), (unknown), Leila Chebane, (unknown), Jean‐Louis Montastruc, Geneviève Durrieu	2
11	Trends of atropinic (anticholinergic) exposure in the elderly: a 10‐year analysis in the French EGB database 2019 ·Fundamental and Clinical Pharmacology ·(unknown), (unknown), François Montastruc, Vanessa Rousseau, Maryse Lapeyre‐Mestre, Jean‐Louis Montastruc	8
12	Breast cancer and spironolactone: an observational postmarketing study 2019 ·European Journal of Clinical Pharmacology ·Pierre Sabatier, Jacques Amar, François Montastruc, Vanessa Rousseau, Leila Chebane, Béatrice Bouhanick, Jean‐Louis Montastruc	4
13	Fluoroquinolones and aortic aneurysms: Which fluoroquinolones are at risk? 2018 ·Archives of Cardiovascular Diseases Supplements ·François Montastruc, Justine Bénevent, Vanessa Rousseau, Leila Chebane, (unknown), Agnès Sommet, Jean‐Louis Montastruc	1
14	Effets indésirables « graves » du tramadol : bilan 2011–2015 de pharmacovigilance en France 2017 ·Therapies ·(unknown), Vanessa Rousseau, Delphine Abadie, Kamel Masmoudi, Joëlle Micallef, (unknown), (unknown), (unknown), François Montastruc, Jean‐Louis Montastruc	22
15	Apport de la visite d’assistants de recherche clinique aux cabinets de médecins généralistes sur la notification des effets indésirables médicamenteux 2016 ·Therapies ·Geneviève Durrieu, (unknown), (unknown), (unknown), Vanessa Rousseau, Haleh Bagheri, Emmanuelle Bondon‐Guitton, Delphine Abadie, François Montastruc, (unknown), Stéphane Oustric, Jean‐Louis Montastruc	9
16	Paradisiacal tombs and architectural rooms in late Roman Sardis: Period Styles and regional variants 2015 ·ISBN ·Vanessa Rousseau	1
17	Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database 2015 ·European Journal of Clinical Pharmacology ·François Montastruc, (unknown), Virginie Gardette, Vanessa Rousseau, Haleh Bagheri, Jean‐Louis Montastruc	10
18	Significance of TP53 mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer 2014 ·Molecular Oncology ·Xiaoli Ma, Vanessa Rousseau, Haiji Sun, Sylvie Lantuéjoul, Martin Filipits, Robert Pirker, Helmut Popper, Jean Mendiboure, A.L. Vataire, Thierry Le Chevalier, Jean Charles Soria, Élisabeth Brambilla, Ariane Dunant, Pierre Hainaut	35
19	Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses 2012 ·Annals of Oncology ·William E. Pierceall, Ken A. Olaussen, Vanessa Rousseau, Élisabeth Brambilla, Kam Sprott, Fabrice André, Jean‐Pierre Pignon, Thierry Le Chevalier, Robert Pirker, Changqing Jiang, Martin Filipits, (unknown), Jeffery L. Kutok, David T. Weaver, (unknown), Jean‐Charles Soria	54
20	Eve and Lilith: Two Female Types of Procreation 2005 ·Diogenes ·Vanessa Rousseau	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact